Comparative Effectiveness of Cell‐Based Versus Egg‐Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022–2023 Season Among Adults 18–64 Years

Documenti analoghi

• Influenza Epidemiology and Vaccine Effectiveness Following Funded Influenza Vaccine in Queensland, Australia, 2022
  di: Ashish C. Shrestha, et al.
  Pubblicazione: (2024)
• Seasonal Influenza Vaccine 2021/2022 Provides Limited Cross Reactivity Against Contemporary Swine Influenza A Virus Strains in Spain
  di: Paloma Encinas, et al.
  Pubblicazione: (2025)
• Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland
  di: Louise Marron, et al.
  Pubblicazione: (2024)
• High‐Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults
  di: Arto A. Palmu, et al.
  Pubblicazione: (2024)
• Effectiveness of Influenza Vaccines in Italy in the 2024/2025 Season: A Nationwide, Test‐Negative Design Study Based on Surveillance Records
  di: Daniel Cifo, et al.
  Pubblicazione: (2026)